Clinical Trial of Prednimustine, Leo-1031 (NSC-134087), in Patients with Non-Hodgkin Lymphomata and Chronic Lymphocytic Leukaemia Previously Treated with Steroids and Alkylating Agents-Reference-Cited by-同舟云学术

Clinical Trial of Prednimustine, Leo-1031 (NSC-134087), in Patients with Non-Hodgkin Lymphomata and Chronic Lymphocytic Leukaemia Previously Treated with Steroids and Alkylating Agents

Published:2009-04-24 Issue:1-6 Volume:207 Page:215-220
ISSN:0001-6101
Container-title:Acta Medica Scandinavica
language:en
Short-container-title:

Author:

Pedersen-Bjergaard J.,Hansen M. Mørk,Geisler C. H.,Nissen N. I.

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.0954-6820.1980.tb09708.x/fullpdf

Reference18 articles.

1. Therapeutic effect of Prednimustine (Leo 1031) in various types of leukaemia;Brandt;Eur J Cancer,1977

2. Use of Prednimustine for remission induction without drug-induced bone marrow aplasia in adult acute non-lymphocytic leukaemia (ANLL);Brandt;Med Oncology,1978

3. Therapeutic effect of Leo 1031, an alkylating corticosteroid ester in lymphoproliferative disorders. I. Chronic lymphocytic leukaemia;Brandt;Acta Med Scand,1975

4. Report of the committee on Hodgkin's disease staging classification;Carbone;Cancer Res,1971

5. A phase II clinical trial of Prednimustine;Clinical Screening Cooperative Group of E.O.R.T.C.;Biomed,1977

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the Cytotoxic Effect of Prednimustine in Cultured Cells with High or Low Levels of Metallothionein;Acta Pharmacologica et Toxicologica;2009-03-13

2. Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma;American Journal of Hematology;1998-10

3. Non-Hodgkin-Lymphome niedriger Malignität;Therapiekonzepte Onkologie;1998

4. Non-Hodgkin-Lymphome niedriger Malignität;Therapiekonzepte Onkologie;1995

5. Non-Hodgkin-Lymphome;Therapiekonzepte Onkologie;1993